Pharma Recent Job Changes
November 4th, 2011 // 12:27 pm @ jmpickett
Viamet Pharmaceuticals named Marc Rudoltz as chief medical officer;
Virobay named David Karpf as chief medicial officer;
Galleon Pharmaceuticals named E. Euan MacIntyre as sr vp, drug discovery;
Galleon Pharmaceuticals named James McLeod as sr vp, clinical R&D;
Sialix hired Norrie Russell as ceo and president;
AbelsonTaylor promoted Matt Collins to vp, director of interactive technology;
H3 Biomedicine hired Markus Warmuth as ceo;
Conatus Pharmaceuticals named Gary Burgess as sr vp & chief medical officer;
Dyax added Ron Cohen to its board;
InterMune added Angus Russell to its board;
Theorem Clinical Research hired John Potthoff as ceo and president;
Theorem Clinical Research hired Adam Serody as vp, global business development;
ICON hired Steve Cutler as group president, clinical research services;
Amarantus BioSciences named Gerald Commissiong as ceo and president;
NeurogesX named Stephen Peroutka as exec vp & chief medical officer;
Threshold Pharma named Nipun Davar as vp of pharma development & manufacturing;
Catabasis Pharma promoted Michael Curtis to sr vp, product development & regulatory affairs;
Quinn Emanuel Urquhart & Sullivan added former Novartis general counsel Tom Werlen as a partner;
Source: Pharmalot
